{"schema_version":"secwatch.filing_event.v1","accession":"0001386570-25-000021","form_type":"8-K","ticker":"NAGE","cik":"0001386570","company_name":"Niagen Bioscience, Inc.","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.278834+00:00","generated_at":"2026-05-17T00:35:12.329016+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Niagen Bioscience Q3 net sales up 33% to $34M, net income $4.6M, raises FY sales growth outlook to 25-30%","bullets":["Net sales $34.0M (+33% YoY); Tru Niagen sales $26.0M (+44% YoY).","Net income $4.6M ($0.06 EPS) vs $1.9M ($0.02 EPS) prior year; adjusted EBITDA $6.4M (+120%).","Gross margin 64.5% (+100 bps); sales & marketing expense as % of sales improved 170 bps to 25.8%.","New FY 2025 outlook: net sales growth 25-30% (from 22-27%); reaffirms momentum in Tru Niagen and Niagen ingredients.","Operational: launched AboutNAD platform, won NAD+ advertising challenge, expanded clinic network to 1,000+ sites."],"urls":{"canonical":"https://secwatch.observer/filing/0001386570-25-000021","json":"https://secwatch.observer/filing/0001386570-25-000021.json","markdown":"https://secwatch.observer/filing/0001386570-25-000021.md","text":"https://secwatch.observer/filing/0001386570-25-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1386570/000138657025000021/0001386570-25-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1386570/000138657025000021/cdxc-20251104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:35:12.329016+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}